We're here for you if you want to talk

0808 2080 888

[email protected]

News and blogs

339 results found.

New blood test for myeloma being researched at Birmingham

Two doctors at the University of Birmingham are developing a new technique to help diagnose and monitor people with the blood cancer, non-measurable myeloma.

17th Jun 2024

Two women in blue lab coats sitting and smiling

Scotland approves two new blood cancer drugs

Two new drugs for the blood cancer, diffuse large B-cell lymphoma DLBCL have been made available for use on the NHS in Scotland as a third-line treatment.

10th Jun 2024

Jacqueline, in remission from DLBCL, stands smiling in the sunshine with a city skyline blurred in the background.

Blood cancer treatment for a form of acute myeloid leukaemia approved for use on NHS

New blood cancer treatment for acute myeloid leukaemia (AML) with IDH1 mutation. The National Institute for Health and Care Excellence (NICE) approved Ivosidenib (Tibsovo) with azacitidine has made it available to those in England and Wales.

24th May 2024

A researcher in a lab, conducting an experiment using a pipette.

What's the latest evidence regarding COVID-19 vaccines and blood cancer?

Lots of information continues to circulate about COVID-19 and vaccinations for immunocompromised people. Blood Cancer UK’s Healthcare Professional Advisory Panel (HPAP), made up of specialists from across the UK working in haemato-oncology and related professional fields, has released the statement below to help you understand the latest evidence.

15th May 2024

Covid vaccine bottles

One year later – are we still on track?

Back in 2022, Blood Cancer UK created a new five-year strategy. We made a commitment back then to shape that strategy alongside the Blood Cancer UK community, and to give regular updates. We're now at the end of year one, so it’s the perfect time to stop, reflect and consider whether we're on track.

13th May 2024

Blood Cancer UK's CEO, Helen Rowntree, holding a Blood Cancer UK coffee mug in the office and smiling.

Prime Minister recognises blood cancer fundraiser

James Badger, from Harrogate who is raising £300,000 for Blood Cancer UK after his wife passed away from leukaemia has received Prime Minister Rishi Sunak’s Points of Light award.

8th May 2024

Two men cycling

Snowman author leaves gift to Blood Cancer UK

Blood Cancer UK are one of three charities left a gift in the Will of the author and illustrator Raymond Briggs, CBE.

1st May 2024

Man smiling

Selinexor recommended in draft final guidance for myeloma

The drug, selinexor has been recommended by NICE in final draft guidance for use in people with myeloma if previous treatment has failed.

22nd Apr 2024

Older Black woman holding mug and looking into the distance

Minreet's marathon for mum with myeloma

Minreet and the Skipping Sikh will run the London Marathon for Blood Cancer UK to give hope to their mum who is receiving treatment for the blood cancer, myeloma

18th Apr 2024

Two women smiling at camera

CAR-T therapy Kymriah available for a form of childhood and young-adult leukaemia on the NHS

'Life-changing' blood cancer drug, Kymriah is now available routinely on the NHS for childhood and young-adult B-cell acute lymphoblastic leukaemia on the NHS

11th Apr 2024

Young adult, women, sat smiling at camera

How a Yorkshire house led to five pioneering research projects

Last year you raised an incredible £1.95m for Blood Cancer UK in the Omaze Millon Pound House Draw. Find out more about the incredible research projects this is helping to support.

11th Apr 2024

A group of people happy holding up the amount of money raised.

Omaze x Blood Cancer UK Research Fund launched

Blood Cancer UK reveals that the money from their latest partnership with Omaze UK is their largest single donation to date. The money has now been invested into research via the Omaze x Blood Cancer UK Research Fund.

19th Mar 2024

A man and a women in Blood Cancer UK lab coats smiling at the camera

Louis Walsh's blood cancer

Walsh has a rare form of blood cancer, which affects the plasma cells in the blood.

15th Mar 2024

Louis Walsh in blue jumper sitting wearing pin badge

Scotland drug regulators rule blood cancer isn't cost effective

Yescarta, the blood cancer drug is not to be made available on the NHS in Scotland even though it is in England. Blood Cancer UK says it highlights the inequality in access to blood cancer drugs across the UK.

12th Mar 2024

A man having chemotherapy in hospital

Ambitious £4 million project to develop clinical platform for blood cancer prevention

World Cancer Day sees Blood Cancer UK and The Leukemia & Lymphoma Society announce the start of a transformative five-year, £4 million research project in Cambridge. The work will establish a clinical platform to identify individuals at high risk of certain blood cancers and develop interventions to prevent people from progressing to these diseases.

4th Feb 2024

Man in red lab coat working with a women and man in white lab coats

Non-Hodgkin lymphoma drug, Tepkinly, authorised for use on NHS

Tepkinly (epcoritamab), a treatment for the blood cancer, diffuse large B-cell lymphoma is to be made available on the NHS as a third line treatment.

1st Feb 2024

Jacqueline, in remission from DLBCL, smiles whilst holding a phone to her ear, standing outside in front of a house.

From despair to hope: The Matthew Wilson Multiple Myeloma Fund

Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.

26th Jan 2024

Matthew Wilson, a member of the Board, smiling against a plan white background.

Our response to the Government's plan for UK commercial clinical trials

Refreshing clinical trials activity must benefit people with blood cancer across the UK.

18th Jan 2024

Photo by R Spegel on Unsplash

Cards for when "get well soon" doesn't quite cut it

We're thrilled to announced our partnership with artist Vicky Yorke, whose unique card designs and messages draw from her own experience of chronic myeloid leukaemia (CML) – with every purchase supporting life-saving blood cancer research.

12th Jan 2024

Vicky Yorke empathy cards

Insurance leader Matthew Wilson to be next chair of trustees of Blood Cancer UK

Blood Cancer UK will appoint insurance leader, and advisor to Fairfax Financial and Lloyd’s of London, Matthew Wilson as its next chair of trustees. Matthew, who has been appointed after a robust, independent recruitment process, will formally start his role in early 2024, as current chair John Ormerod’s term comes to an end after 5 years in post.

1st Dec 2023

Man smiling in a suit